Digital transformation is a term that is hard to define concisely, but for organizations in multiple industries will at least point to the adoption of a data management infrastructure that allows their laboratories to work faster and more productively, with greater transparency. More than just working towards a paperless lab, digital transformation may allow companies to derive more intelligence from their data, ultimately improve product and process safety, and enable faster regulatory audit or approval timelines.
May 27, 2020 - Thermo Fisher Scientific to Showcase New Mass Spectrometry Systems and Software During Virtual ASMS Event
Thermo Fisher Scientific Inc., will provide online programming and virtual exhibits to introduce scientists to a number of new products that build on its leading Orbitrap platform and expand research applications. Digital programs will enable scientists to broaden mass spectrometry-based research, from proteomics and biotherapeutics to clinical applications
C3.ai, anenterprise AI software provider for accelerating digital transformation, today announced the addition of 11 new integrated COVID-19 data sets to the C3.ai™ COVID-19 Data Lake, making it one of the largest pre-integrated and free sources of COVID-19 data in the world. C3.ai COVID-19 Data Lake offers researchers access to normalized, unified data to accelerate efforts in the fight against COVID-19.
The latest edition of the longtime industry reference guide to systems, vendors, information and resources concerning laboratory data management has been made available to the public.
As countries begin to ease restrictions and allow some businesses to reopen, contact tracing and epidemiological studies will be critical to understand resurgence of potential COVID-19 outbreaks. Scientists not only need to know who is infected, they also need to rapidly identify which strain of the virus is spreading. To expedite such analysis, Thermo Fisher Scientific has now optimized its Ion AmpliSeq SARS-CoV-2 Research Panel for the Ion Torrent Genexus System.
May 12, 2020 - Matrix LIMS Used by Liverpool GCPLab in UK Wide Tracking of COVID-19 Patient Outcomes
The Liverpool Good Clinical Practice Laboratory (GCPLab) Facility directed by Professor Bill Greenhalf, has a crucial role in supporting the International Severe Acute Respiratory and Emerging Infection Consortium. To improve delivery and provide better standardisation the Glasgow team wanted to use the same MATRIX LIMS system as Liverpool, Autoscribe were asked to help and stepped in to provide licences for the MATRIX system, allowing remote access for Glasgow to the Liverpool database.
Abbott Informatics is proud to announce the availability of the STARLIMS Technology Platform v12. This milestone in the evolution of the Technology Platform (TP) brings numerous enhancements and fixes that will help with the proper operation and maintenance of your STARLIMS system.
Bringing new levels of field sampling optimization, compliance and field data collection, Autoscribe Informatics has announced the integration of Trilogy TAPS sample planning and scheduling management software with its Matrix Gemini configurable laboratory information management system (LIMS). Integration of field data collection and laboratory activities is especially useful in water, environmental, waste and similar industries.
Benchling, the leading life sciences R&D cloud, today announced the launch of Benchling Insights, a new solution that gives life sciences companies the ability to query, visualize and collaborate around high quality, structured data that resides on the platform. Benchling Insights delivers a 360-degree view of scientific programs and operations to drive faster, more informed decision-making.
April 28, 2020 - Proscia® Offers Concentriq® Digital Pathology Software for Remote Use in Clinical Practice in the United States
Proscia® has made available the Concentriq Dx® digital pathology software for use in reviewing and reporting of digital pathology slides in the United States. Concentriq Dx, which is CE-marked for use in primary diagnosis in Europe, will support the need for remote pathology in the United States brought about by the COVID-19 pandemic.
April 21, 2020 - Eurofins Genomics U.S. launches new SARS-CoV-2 plasmid DNA controls and increases its capacity to produce probes and primers, all of which being key components of SARS-CoV-2 RT-PCR testing
Eurofins Genomics U.S. announces that, together with its subsidiary BlueHeron Biotechnology, it has launched a series of SARS-CoV-2 plasmid DNA controls that can be used to verify the presence of the SARS-CoV-2 virus. They are intended to be used for both research and development and IVD diagnostic applications.
April 21, 2020 - Illumina Makes Software Toolkit Available Free of Charge to Support Worldwide Efforts to Combat COVID-19
Illumina, Inc. announces the Illumina SARS-CoV-2 Data Toolkit, a new suite of data analysis tools and workflow functionality for researchers working with the virus using next-generation sequencing (NGS). The toolkit makes it easier for researchers to detect and identify the SARS-CoV-2 viral sequence in their samples and contribute their findings to critical public databases. Illumina is making the toolkit available at no cost to the global research community in support of efforts to combat the pandemic.
Autoscribe Informatics is delighted to announce that it has appointed Promatics Technologies Nigeria as our distributor in Nigeria to sell, configure and support the Matrix family of Laboratory Information Management System (LIMS) products. Based in Abuja, Nigeria, Promatics Technologies provide a range of technology services and consulting solutions, including healthcare and clinical systems, to clients across the region.
L7 Informatics Inc., and Contamination Source Identification (CSI) deploy ‘ready to go’ COVID-19 workflows based on the CDC testing protocol for testing laboratories supporting coronavirus patient screening.
Hidex Sense microplate reader used to research mechanisms, diagnostics, and therapeutic targets of SARS-CoV-2. As the global COVID-19 (also known as SARS-CoV-2) crisis continues to unfold, it’s important to recognise the scientists behind the vital studies investigating the virus. The current pressing task of epidemiologists and virologists around the world is studying the mechanisms and transmission of SARS-CoV-2, to better understand the virus whilst revealing therapeutic targets.
April 14, 2020 - Bruker partners with ANPC to support major new frontline response to combat the COVID-19 threat
Bruker is proud to partner with Australian National Phenome Centre (ANPC) at Murdoch University to support the work of their researchers into the COVID-19 pandemic threat. The ANPC team has launched a major research and diagnostics project to better understand and predict variation in COVID-19 severity and determine the complex genetic, environmental and lifestyle interactions that influence its pathogenicity in individuals. Later they will engage with clinical trials of novel antiviral agents and when available vaccines in order to predict responder/non-responder outcomes.
April 14, 2020 - Visiopharm and Proscia® Partner to Deliver AI-Enabled Solutions that Advance Precision Medicine
Visiopharm, the leader in precision pathology software, and Proscia, a leader in digital pathology image and workflow management, have entered into a multi-year, strategic partnership to deliver deeply integrated AI-enabled solutions that drive breakthroughs in translational research and advance precision medicine.
April 7, 2020 - Thermo Fisher Scientific Launches New AcroMetrix Coronavirus 2019 (COVID-19) RNA Control (RUO)
hermo Fisher Scientific announces the availability of the Thermo Scientific AcroMetrix Coronavirus 2019 (COVID-19) RNA Control, its latest quality control product to monitor and validate COVID-19 molecular diagnostic tests.
John Wiley and Sons Inc. today announced the acquisition of Bio-Rad Laboratories, Inc.’s Informatics products including the company’s spectroscopy software and spectral databases.
EccoVia Solutions, a leading provider of health and human services cloud-based solutions, announces today that they have successfully completed the implementation of a COVID-19 screening tool in the company’s signature software platform, ClientTrack©.